System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Journal Article Review Epublish

PubMed: 42063669 DOI: 10.1177/17562848251408408

The GETAID: over 40 years of academic research in IBD.

Ther Adv Gastroenterol 19:17562848251408408

Authors: David Laharie, Arnaud Bourreille, Mathurin Fumery, Charlotte Mailhat, Lucine Vuitton

Affiliations

  • CHU de Bordeaux, Hôpital Haut-Lévêque, Service d'Hépato-gastroentérologie et Oncologie Digestive, Université de Bordeaux, Bordeaux F-33000, France.
  • CHU de Bordeaux, Centre Medico-chirurgical Magellan, Hôpital Haut-Lévêque, Gastroenterology Department, Université de Bordeaux, INSERM CIC 1401, Bordeaux, France.
  • Nantes Université, CHU de Nantes, Hôtel-Dieu, Hépato-gastroentérologie, Institut des Maladies de l'Appareil Digestif, CIC Inserm 1413, Nantes, France.
  • Department of Gastroenterology, Amiens University Hospital, and PeriTox, Université de Picardie, Amiens, France.
  • GETAID, Paris, France.
  • CHU de Besançon, Service de Gastroentérologie, UMR Inserm Right 1089, Université Marie et Louis Pasteur, Franche-Comté, Besançon, France.

Abstract

Founded in 1983 in Paris by Professor R. Modigliani, the Groupe d'ETude des Affections Inflammatoires Digestives (GETAID) was established to develop collaborative clinical research on inflammatory bowel disease (IBD). This was innovative 40 years ago and remains challenging today. From the beginning, this multicenter group has aimed to address clinical questions arising from patients, physicians, and the IBD community by conducting clinical research on treatments through randomized controlled trials, prospective cohorts, index creation, and observational studies. GETAID has advanced IBD knowledge by publishing over 140 original articles in peer-reviewed journals. This review explores the history of the GETAID, how it functions, and its contribution to IBD knowledge over the past four decades. It illustrates the disruptive and innovative academic research conducted by an independent group of researchers and its potential future impact through examples.

MeSH

Biomedical Research, Inflammatory Bowel Diseases, Research, Colitis, Ulcerative